Vanguard Portfolio Management 13D/13G Filings for Haemonetics Corporation (HAE)

Vanguard Portfolio Management 13D and 13G filings for Haemonetics Corporation:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-04-29
1:38 pm
Purchase
2026-03-3113GHAEMONETICS CORP
HAE
Vanguard Portfolio Management2,600,145
5.590%
2,600,145increase
(New Position)
Filing